StockGuru Blog: IDGLOBAL Snags Ten Year Contract with Leader in Pharmaceutical Labeling

IDGJ: Snags Ten Year Contract with Leader in Pharmaceutical Labeling!

StockGuru ProfileIDGlobalIDGJ

IDGLOBAL’s ten year contract to supply its Nano-Molecular Marking(TM), anti-counterfeiting technology, to ATL Pharma Security Label Systems(TM) (www.atlco.com), a division of Ad Tape & Label Co. comes at time when even Canada admits it does not have the manpower to manage the deluge of counterfeits Canada is experiencing.

This contract gives IDGJ the opportunity to do what it does best: track countefeiting AND to do it for ten years!

This 10-year supply contract guarantees ATL the ability to incorporate IDGlobal’s Nano-Molecular Marking(TM) technologies into any of ATL’s Pharmaceutical labeling solutions. ATL’s labeling prevents counterfeiting and diversion of products to help provide their client base a ‘workable’ pedigree solution. ATL is well known in the pharmaceutical community and is already an approved supplier in the manufacturing of high quality pharmaceutical labels. The transition to include anti-counterfeiting labels is a natural evolution of value-added products and services.

ATL is one of the world’s leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in “private brand” disposable medical device manufacturing.

Perhaps there is no more important industry than the pharmaceutical industry for counterfeit tracking.

The unique labeling that IDGJ can provide is crucial for both Canada and the world. Recently a British Columbian woman was fatally poisoned by counterfeit anxiety pills she ordered over the Internet, four Ontario patients died after apparently consuming fake — and ineffective — heart drugs, while Quebec vendors sell knock-off Viagra at a flea market.

The peddling of bogus pharmaceuticals is becoming such a worrisome problem that Health Canada has begun drafting a new anti-counterfeit strategy, expected to include beefed-up enforcement, stronger ties with police and a public-education campaign.

The situation in Canada is not as serious as in some developing countries, where as many as half the prescription drugs on the market are imitations. In a recent Nigerian editorial it was noted that almost every product on the Nigerian market, imported or locally made, has a counterfeit version. The result is that when you want to buy something, the vendors themselves are the very ones to ask you whether you want the original or the fake.

Counterfeit drugs have emerged globally as a major problem in the last five years, with one U.S. organization predicting that worldwide sales could reach $75-billion by 2010. Criminally minded counterfeiters can make copies of expensive pills cheaply, sell them cheaply and earn a healthy profit.

Bogus medication is increasingly showing up through unregulated Internet sites and even, in less common cases, at those licensed, real pharmacies.

Fraudulent copies of popular drugs have even been used to finance terrorists, U.S. police allege. Five Canadian men were among those charged last year with selling a variety of counterfeit goods and funneling the money to Hezbollah, the Lebanese extremist group.

Impotence drugs like Viagra, Cialis and Levitra are particularly popular with counterfeiters, who can sell them over the Net –or in flea markets — to normally careful consumers who are too embarrassed to seek out a prescription from a doctor. Around two thirds of counterfeits that arrive in Canada are from China.

The recent execution of former head of China’s food and drug administration, Mr. Zheng Xiaoyu, for approving untested drugs in exchange for a bribe of $832,000 underscores the seriousness of the problem.

The IDGLOBAL Supply contract for anti-counterfeiting technology guarantees ATL the ability to incorporate IDGLOBALS’ Nano-Molecular Markers into any Pharmaceutical labeling solution. ATL and IDGLOBAL are already well positioned to address the massive counterfeiting concerns with unique, patented, Trademark proprietary solutions that no one else can provide. This will be extended to the mainstream OTC (over the counter) pharmaceutical product labeling opportunities with companies that are already solid, long-term ATL clients, as well as the emerging “nutraceutical” products manufacturers.

IDGLOBAL has two primary divisions, its Nano-Molecular Markers / Tags(TM) used in anti-counterfeiting applications and its IDFORENSIX(TM) products utilized in Loss Prevention for the $800 billion Anti-Counterfeiting and Loss Prevention markets.

IDGLOBAL’s Nano-Molecular Markers(TM) are the equivalent of taking the laboratory into the field and providing a verifiable answer as to a products authenticity in a matter of seconds by utilizing proprietary Nano-Molecular Markers(TM) and handheld scanning technologies. IDGLOBAL provides its Nano-Molecular Markers(TM) on a global basis and can easily be applied to product runs into the hundreds of millions of units at a cost of a fraction of a penny per unit. IDGLOBAL has established a multi-year track record of aiding in the protection of corporate assets and brand-name goods for major companies across North America. The Company is reviewing key alliance and acquisition opportunities to fast track growth and profitability.

IDGLOBAL Corp. has been publicly traded company since May 2006, and is currently trading under the Pink Sheet stock symbol IDGJ. An essential component of the Company’s business plan is to stay current with its financial statements have these statements reviewed each quarter by appropriate auditors. IDGJ will have all of the required regulatory filings ready to be submitted-along with Form 10-to the SEC.

Source: IDGJ, Reuters, The Financial Times, All Africa

IDGLOBAL Corporation #6
1925 Kirschner Road Kelowna
BC Canada V1Y 4N7
Phone: (250) 862-8933 Toll Free: (866) 922-4345
Fax: (250) 862-8322 Email: ir@idglobalcorp.com

About IDGJ: Business Description: IDGLOBAL manufactures and sells proprietary security products for Anti-Counterfeiting and Loss Prevention markets. IDGLOBAL has established a multi-year track record aiding in the protection of corporate assets such as tools, raw materials, inventory, computers, works of art, sports memorabilia and brand name goods for major companies across North America.

Disclosure: Pentony Enterprises LLC expects to be compensated $15,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. Forward-Looking Statements: This release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the Company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) BBDS’ ability to manage the future acquisitions and the expansion of operations; (2) BBDS’ ability to obtain contracts with suppliers of raw materials (for our production of biodiesel fuel) and with distributors of our biodiesel fuel product; (3) the risks inherent in the mutual performance such supplier and distributor contracts (including our production performance); and (4) BBDS’ ability to raise necessary financing to execute the Company’s business plans.

Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC,9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.

Archives

Select A Month
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered